glp 1 type 1 diabetes SGLT2i and GLP-1 RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia Long-Term Outcomes of GLP-1 Therapies

doi: 10.5662/wjm.v12.i4.246

Promising Results: Early trials showed promising weight loss results, with participants losing an average of 5-13% of their body weight after taking Danuglipron for several months

Additionally, in the analyses of WL after surgery and before treatment, the intercepts were also positive for age with p-value = 0.07 and p-value = 0.09 for GLP-1RAs and placebo treatment groups, respectively, suggesting that older age may be associated with slightly reduced WL

January 22, 2019

Make any changes to a patient's insulin regimen under close medical supervision with increased frequency of blood glucose monitoring